Nonhlanhla N. Mkhize

National Health Laboratory Service — South Africa

Immunology and Microbiology · Life Sciences

24h-index2.1kcitations104works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(54), HIV/AIDS drug development and treatment(21), Monoclonal and Polyclonal Antibodies Research(17), HIV/AIDS Research and Interventions(15), Reproductive tract infections research(13)

Publications104 total

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential
2025Open Access
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials
2025· 1 citedOpen Access
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
UNC Libraries·2025Open Access
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Nature Immunology·2025· 2 citedOpen Access
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nature Communications·2025· 1 citedOpen Access
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study
PLOS Global Public Health·2025Open Access
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody
2025· 1 citedOpen Access
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
2025Open Access
<i>Plasmodium falciparum</i> Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults
The Journal of Infectious Diseases·2025Open Access
BRAVE: a highly accurate method for predicting HIV-1 antibody resistance using large language models for proteins
2025Open Access
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials
2025· 1 citedOpen Access
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
The Lancet HIV·2025· 3 cited
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies
Journal of Virology·2025· 3 citedOpen Access
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines
Frontiers in Immunology·2025· 2 citedOpen Access
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
2025Open Access
Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns
Journal of Clinical Investigation·2025· 1 citedOpen Access
Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance
Journal of Virology·2025· 4 citedOpen Access
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies
2025Open Access
Safety, Pharmacokinetics, and Neutralization Activity of PGDM1400LS, VRC07-523-LS, and PGT121.414.LS Infused Intravenously or Subcutaneously: A Phase 1 Randomized Trial (HVTN 140/HPTN 101 Part B)
SSRN Electronic Journal·2025Open Access
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns
2024· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Lynn Morris(26), Penny L. Moore(16), Jo‐Ann S. Passmore(13), Linda‐Gail Bekker(12), Glenda Gray(12), Georgia D. Tomaras(12), David C. Montefiori(12), Salim S. Abdool Karim(11), Peter B. Gilbert(11), Lawrence Corey(11), Carolyn Williamson(10), Nigel Garrett(9), Allan C. deCamp(7), Shelly Karuna(7), Simone I. Richardson(7), Bronwen E. Lambson(7), Hoyam Gamieldien(6), Quarraisha Abdool Karim(6), Tandile Hermanus(6), James G. Kublin(6)